Faculty Opinions recommendation of CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.
Prediman K. Shah(Cedars-Sinai Medical Center)
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
July 24, 2019
Cited by 0
Related Papers
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
|The Lancet|2012|739
From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
|The American Journal of Cardiology|2006|635
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2017|329